Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
Patenting strategy is more to patenting than simply meeting the formal requirements of a patent office. To win the competitive battle in multi-invention contexts, it is crucially important that a firm develop and align its patent strategy with its business strategy and model from the beginning. In many industries, companies are faced with a “multi-invention problem”: the development of new, commercially viable products requires the combination of ever- larger numbers of inventions. At the same time, ownership over these inventions – through patents and other forms of intellectual property (IP) is becoming increasingly fragmented. There is no easy answer to this question. Many inventors are keen to apply for a patent as early as possible - yet many successful companies delay filing until products are almost ready for market. One disadvantage of early filing is that you may incur substantial costs before you know whether your idea is commercially viable. Applicants have up to two years from filing before becoming liable for significant patent fees, but this is rarely long enough to reach a licensing agreement with a company. It may not even be long enough to establish the commercial prospects of an invention. The private and public sector entities can create comprehensive IP portfolios of substantial value. For both sectors, patents are a key element for producing that value, but an IP portfolio can also take advantage of other forms of protection: trademarks, copyrights, or trade secrets. To give a fuller sense of these options, the chapter provides a helpful set of IP-related terms, and details the variety of patents available with their respective limitations and strengths. Each form of IP protection has its trade-offs. Patents offer firm protection but high costs. In order to know what strategy to pursue, an organization should know what it has. The first step, therefore, in developing an IP strategy is to document what technologies already exist in the organization and what technologies are in development. This is usually accomplished through a freedom to operate study or IP audit. Several forms of intellectual property may be used for the same invention or improvement, and both offensive and defensive strategies may be used. Timing strategies for patent: • Publication • Seminar presentations • Poster presentations • Abstract submissions for conferences OMICS Group is an Open Access publishing journals that is responsible for the dissemination of scientific process and research articles to the global community. Its Open Access journals Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Publishing Group having over 300 leading peer reviewed Open Access journals and has organized more than 300 scientific conferences all over the world. OMICS Group has more than 1000 scientific associations and 30,000 editorial board members and 3.5 million readers to its credit. OMICS Group is a pioneer and leading Science event organizer. OMICS Group International Conferences 2014 and 2015 are instrumental in providing a momentous platform for the world renowned scientists, researchers, students, academicians, institutions, entrepreneurs and industries through International Science Conferences. The main vision and mission of OMICS Publishing Group is to provide free access to scientific literature for quick dissemination of scientific updates and it also provides source of reference and retrieval free of cost. OMICS Group organizes International conferences and Annual meetings in association with organizing committees across the world. OMICS Group conferences bring together scientists, researchers and practitioners to discuss methodological innovations, practical applications and new findings in the research areas of Science, Technology and Management. Research fellows and professors in various disciplines submit works in the form of manuscripts which undergo quality check before being approved for publication.
Pharma Patents Conferences in 2015: 1. International Patent Information Conference & Exposition 2. Global Intellectual Property Convention 3. Drug and Medical Device Litigation 4. Trade Secrets Protection & Enforcement 5. Pharma & Biotech Patent Litigation 6. Effective Trade Mark Administration 7. Best Practices For Selling Your Patents 8. Certified Patent Valuation Analyst 9. EU & US Patent Applications Lists of Societies related to pharma: 1) International Society for Pharmaceutical Engineering (ISPE) 2) American Association of Pharmaceutical Scientists (AAPS), USA 3) Austrian Association of Hospital Pharmacists (AAHP), Australia 4) Canadian Society for Pharmaceutical Sciences (CSPS), Canada 5) Chinese Pharmaceutical Association (CPA), China 6) European Federation for Pharmaceutical Sciences (EUFEPS), Europe 7) German Pharmaceutical Society (DPhG), Germany 8) Indian Pharmaceutical Association (IPA), India Major Pharma and related Companies: 1) Pfizer, USA 2) Novartis, Switzerland 3) Merck & Co., USA 4) Bayer, Germany 5) GlaxoSmithKline, U K 6) Johnson & Johnson, USA 7) Sanofi, France 8) Hoffmann–La Roche, Switzerland 9) AstraZeneca, UK 10) Abbott Laboratories, USA 11) Bristol-Myers Squibb, USA 12) Eli Lilly and Company, USA 13) Amgen, USA 14) Takeda Pharmaceutical Co., Japan
This page will be updated regularly.
This page was last updated on 09th Oct, 2014
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising